Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
Elisabeth SmitsFelicita AndreottiEline HoubenHarry J G M CrijnsSylvia HaasGeorge SpentzourisCristina RebordosaRosa GiniClaudia BartoliniFernie J A Penning-van BeestRon HeringsPublished in: Drugs - real world outcomes (2022)
Adherence to treatment was high. In Germany, adherence was markedly higher in QD users compared with BID users. In Italy and the Netherlands, these differences were marginal. Persistence was low in all countries, but discontinuation was temporary. Only in Germany, persistence was markedly lower in BID users vs QD users.